Palatability of a Novel Oral Formulation of Prednsione

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-12-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prednisone solution USP (5mg/5mL), is the most commonly prescribed formulation of prednisone to pediatric and adult patients. The rationale for this study is that palatability is the most important determinant of pediatric patient compliance, and therefore, it is critical that the Orbis formulation be perceived as significantly more palatable compared to today's commercially available products in order to warrant further development of the TP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PF-06651600 Taste Study.

NCT03916393

Healthy Participants

COMPLETED PHASE1

A Taste Assessment of BMS-986165 in Healthy Participants

NCT03751228

Healthy Participants

COMPLETED PHASE1

Biomarkers of Prednisolone Treatment (P05888)

NCT00971724

Insulin Resistance Hyperglycemia Glucose Intolerance

COMPLETED NA

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

NCT06124144

Leishmaniasis

TERMINATED PHASE1

Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits

NCT01734759

Healthy

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palatability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Adults

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 to 32 years, male and female who are healthy at the time of study
* can demonstrate holding 10 mL of apple juice in mouth for 5 seconds without swallowing and then expectorate contents into a cup
* demonstrate ability to complete study questionnaire

Exclusion Criteria

* history of smoking or using any tobacco products
* previous history of taste disturbance
* any condition or dietary habit known to interfere with the sense of smell and taste
* any structural or functional abnormality of the upper gastrointestinal tract
* ingestion of any medication or nutritional supplement (with exception of acetaminophen tablets or capsules) in a 48 hour period prior to study
* history of any significant illness within the two weeks prior to study
* history of autonomic dysfunction, bronchospastic disease or atopic allergy
* known hypersensitivity (ie., allergic reaction) to any drug, food coloring agent or artificial sweetener
* any history of participating in a clinical trial of a drug or device within a 30 day period from the time of study
* brushing of the teeth, usage of mouthwash, and or oral ingestion of any substance within two hours of receipt of the initial test article and
* inability to speak and/or read English at a grade 10 level

Minimum Eligible Age

18 Years

Maximum Eligible Age

32 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes